Human cytomegalovirus immediate-early intron A

Intron from the human CMV immediate-early gene that enhances transgene expression 3-4 fold through efficient splicing and mRNA processing. Widely used in commercial expression vectors (pcDNA3, pIRES) and characterized by Chapman et al. in 1991 as a key element for mammalian gene expression.

Length: 814 bp

Subtype: Intron

Origin: Human cytomegalovirus immediate-early gene

Characteristics

814 bp intron located within the CMV immediate-early transcription unit, recognized and processed by cellular splicing machinery with high efficiency in mammalian cells. When incorporated into expression vectors downstream of the CMV promoter or other strong promoters, enhances steady-state mRNA levels and protein output through splicing-dependent mechanisms. Xu et al. (2018) demonstrated 3.69-fold expression enhancement over control IVS intron in stable CHO cell lines with 76.0% high-level expression colonies. The intron functions through recruitment of exon junction complex components that enhance nuclear export via TREX complex binding and improve mRNA stability. Splicing efficiency >85% in most mammalian cell types.

Applications: Standard component in widely-used commercial expression vectors including Invitrogen's pcDNA3 series and pIRES vectors for mammalian cell transfection and stable cell line generation. Particularly effective when combined with CMV promoter for high-level constitutive expression in transient transfection experiments. Used in both plasmid-based and viral vector systems (lentiviral, adenoviral) for enhanced transgene expression. Suitable for applications requiring moderate to high expression levels in cultured mammalian cells, particularly CHO, HEK293, and COS cells.

Limitations: Larger size (814 bp) compared to synthetic or minimal introns reduces available cargo space in size-constrained viral vectors like AAV where every base pair matters. Showed lower transfection efficiency (43.2%) compared to SV40 small t intron (85.3%) in Xu 2018 study, possibly due to plasmid size effects. Requires active splicing machinery and may not function optimally in cell types with compromised spliceosome activity. The benefit is context-dependent and may vary between cell types and expression systems. Less commonly used in modern AAV vector design where smaller elements are preferred.

Mechanism: Processed by the cellular spliceosome via recognition of canonical 5' donor and 3' acceptor splice sites. Upon splicing, recruits the exon junction complex (EJC) that remains bound 20-24 nucleotides upstream of the exon-exon junction. This EJC enhances nuclear export by recruiting mRNA export factors (TREX complex), increases translation efficiency during the pioneer round of translation, and stabilizes the mRNA by marking it as properly processed. The splicing event itself triggers remodeling of the mRNP structure that favors nuclear export over degradation. Net effect is 3-4 fold increase in protein output primarily through enhanced mRNA stability and nuclear export rather than increased transcription rate.

Sequence

You must be signed in to view the full sequence.

Sign in / Register

References

  1. Chapman et al. (1991). Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells. Nucleic Acids Res. - Chapman 1991 hCMV Intron
  2. Xu et al. (2018). SV40 intron, a potent strong intron element that effectively increases transgene expression in transfected Chinese hamster ovary cells. J. Cell. Mol. Med. - Xu 2018 Intron Comparison